A New Wave of PI3Kα Inhibitors.

Overview of attention for article published in Cancer Discovery, November 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

So far, Altmetric has seen 23 X posts from 16 X users, with an upper bound of 63,360 followers.

RT @CD_AACR: In the Spotlight from the latest issue: A new wave of PI3Kα inhibitors by @AlisonLKearney and @NeilVasan. https://t.co/Z5KikP9…

RT @CD_AACR: In the Spotlight from the latest issue: A new wave of PI3Kα inhibitors by @AlisonLKearney and @NeilVasan. https://t.co/Z5KikP9…

RT @CD_AACR: In the Spotlight from the latest issue: A new wave of PI3Kα inhibitors by @AlisonLKearney and @NeilVasan. https://t.co/Z5KikP9…

RT @CD_AACR: In the Spotlight from the latest issue: A new wave of PI3Kα inhibitors by @AlisonLKearney and @NeilVasan. https://t.co/Z5KikP9…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 19 additional X posts.